Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Opinion in Oncology|May 29, 2014
Isocitrate dehydrogenase mutations in chondrosarcoma: the crossroads between cellular metabolism and oncogenesisGeorges Azzi, Michel Velez, Maria C Mathias-Machado
Case Reports in Oncology|October 9, 2025
Advanced Minimal Residual Disease Detection Using a Novel Circulating Tumor DNA Assay: A Report of Two CasesGeorges Azzi, Thomas P Slavin, Jesus Izaguirre-Carbonell, et al.
Bioorganic & Medicinal Chemistry Letters|January 7, 2016
Novel carbocyclic nucleoside analogs suppress glomerular mesangial cells proliferation and matrix protein accumulation through ROS-dependent mechanism in the diabetic milieu. II. Acylhydrazone-functionalized pyrimidinesKamal H Bouhadir, Ali Koubeissi, Fatima A Mohsen, et al.
Annals of Human Genetics|September 26, 2015
Hypovitaminosis D in a Young Lebanese Population: Effect of GC Gene Polymorphisms on Vitamin D and Vitamin D Binding Protein LevelsMyrna Medlej-Hashim, Rania Jounblat, Aline Hamade, et al.
Scientific Reports|October 24, 2019
Prevalence of HIV and other sexually transmitted infections and their association with sexual practices and substance use among 2238 MSM in LebanonAyman Assi, Sara Abu Zaki, Jade Ghosn, et al.
Case Reports in Oncology|June 15, 2022
Treatment Response Monitoring Using a Tumor-Informed Circulating Tumor DNA Test in an Advanced Triple-Negative Breast Cancer Patient: A Case ReportGeorges Azzi, Shifra Krinshpun, Antony Tin, et al.
International Journal of General Medicine|July 13, 2013
Effects of proton pump inhibitors and electrolyte disturbances on arrhythmiasElie El-Charabaty, Chadi Saifan, Mokhtar Abdallah, et al.
NPJ Breast Cancer|November 5, 2022
Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancerNeelima Vidula, Andrew Lipman, Shumei Kato, et al.
The Oncologist|December 23, 2022
Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell CarcinomaGeorges Azzi, Mehrad Tavallai, Vasily N Aushev, et al.
Journal for Immunotherapy of Cancer|November 3, 2024
Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT studyKevin C Flanagan, Jon Earls, Jeffrey Hiken, et al.
Pageof 2